However, limited evidence suggests that LIF activates STAT3 signaling, but studies have focused on the effects of secreted LIF and LIFR, while there is a lack of research on other effects of LIF on HCC, and small molecule inhibitors of LIF have not been established. The gene discussed is LIF; the disease is hepatocellular carcinoma.